US4501726A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
Assignee: Individual
•
Filing: 1982-11-11
•
Granted: 1985-02-26
•
Expires: 2002-11-11
Abstract
Abstract An intravascularly administrable, magnetically responsive nanosphere or nanoparticle made up of a crystalline carbohydrate matrix, preferably starch, enclosing a magnetic material, is described. The nanosphere or nanoparticle is produced by dissolving a carbohydrate together with a magnetic material to form a solution which is emulsified in a hydrophobic solvent from which the carbohydrate is crystallized. The resulting magnetic nanospheres having an average diameter not exceeding 1500 nm are capable of transporting pharmacologically active substances and can be injected intravenously for subsequent concentration in a part of the body by means of a magnetic field.
Inventors
- 👤 Ulf Schroder
- 👤 Klaus Mosbach
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 06:42
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/5123; A61K9/5094; A61K9/513; A61K9/5146; A61K9/5161; B; B82; B82Y; B82Y25/00; H; H01; H01F; H01F1/00; H01F1/0036; H01F1/0045; H01F1/0063; H01F1/0054; Y; Y10; Y10S; Y10S977/00; Y10S977/70; Y10S977/701; Y10S977/702; Y10S977/706; Y10S977/773; Y10S977/775; Y10S977/776; Y10S977/778; Y10S977/832; Y10S977/838; Y10S977/902; Y10S977/904; Y10S977/915; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2991
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
62 words
A nanosphere or nanoparticle for intravascular administration, which is magnetically responsive and biologically degradable and which is made up of a matrix in which a magnetic material is enclosed, characterized in that said nanosphere or nanoparticle has an average diameter which does not exceed 1500 nm, and circulates in the vascular system after administration thereto, said matrix comprising a hydrophillic, crystalline carbohydrate.
Claim 2
Dependent Claim
62 words
A nanosphere or nanoparticle for intravascular administration, which is magnetically responsive and biologically degradable and which is made up of a matrix in which a magnetic material is enclosed, characterized in that said nanosphere or nanoparticle has an average diameter which does not exceed 1500 nm, and circulates in the vascular system after administration thereto, said matrix comprising a hydrophillic, crystalline carbohydrate.
Claim 3
Dependent Claim
26 words
A nanosphere or a nanoparticle as claimed in claim 1, characterised in that the magnetic material is present in the form of particles or a colloid.
Claim 4
Dependent Claim
30 words
A nanosphere or a nanoparticle as claimed in claim 2, characterised in that the magnetic material consists of magnetite particles having an average diameter of 1-1000 nm, preferably 10-20 nm.
Claim 5
Dependent Claim
28 words
A nanosphere or a nanoparticle as claimed in one or more of claims 1, 2, or 3, characterised in that the crystalline carbohydrate is glucose, maltose or lactose.
Claim 6
Dependent Claim
38 words
A nanosphere or a nanoparticle as claimed in one or more of claims 1, 2, or 3, characterised in that the crystalline carbohydrate is a carbohydrate polymer, preferably with alpha(1-4) bonds between the carbohydrates comprised by the polymer.
Claim 7
Dependent Claim
24 words
A nanosphere or a nanoparticle as claimed in claim 5, characterised in that the carbohydrate polymer is starch, glycogen, pullullan or a derivative thereof.
Claim 8
Dependent Claim
22 words
A nanosphere or a nanoparticle as claimed in claim 5, characterised in that the carbohydrate polymer is dextran or a derivative thereof.
Claim 9
Dependent Claim
26 words
Use of the nanosphere or the nanoparticle as claimed in claim 1 for transport and concentration of pharmacologically active substances in biological systems, preferably animal systems.
References Cited (Backward Citations)
US4357259A
Cited
US4247406A
Cited
US4345588A
Cited
EP0021009A2
Cited
US4331654A
Cited
EP1021330A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-02-26 | 1988-08-27 | 1989-02-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-02-26 | 1992-08-27 | 1993-02-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-02-26 | 1996-08-27 | 1997-02-26 | $7700.00 | Window Closed / Lapsed |